Succinate and malonate salt of trans4-(IR,3S)-6-chloro-3-phenylindan-1-yl)- 1,2,2-trimethylpiperazine and the use as a medicament

Details for Australian Patent Application No. 2004265021 (hide)

Owner H. Lundbeck A/S

Inventors Dahl, Allan Carsten; Howells, Mark; Nielsen, Ole; Svane, Henrik; BangAndersen, Benny; Lyngso, Lars Ole; Ringgard, Lone Munch; Lopez De Diego, Heidi; Collier, Sherry L.

Agent Watermark

Pub. Number AU-B-2004265021

PCT Pub. Number WO2005/016900

Priority PA 2003 01180 18.08.03 DK; PA 2003 01305 11.09.03 DK

Filing date 18 August 2004

Wipo publication date 24 February 2005

Acceptance publication date 27 May 2010

International Classifications

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

C07C 17/16 (2006.01) Compounds containing carbon and halogens with or without hydrogen

C07C 25/22 (2006.01) Compounds containing at least one halogen atom bound to a six-membered aromatic ring

C07C 29/143 (2006.01) Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring

C07C 35/32 (2006.01) Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring

C07D 295/073 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C12P 7/22 (2006.01) Preparation of oxygen-containing organic compounds

C12P 41/00 (2006.01) Processes using enzymes or micro-organisms to separate optical isomers from a racemic mixture

Event Publications

9 March 2006 PCT application entered the National Phase

  PCT publication WO2005/016900 Priority application(s): WO2005/016900

26 June 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 06 Jun 2008

27 May 2010 Application Accepted

  Published as AU-B-2004265021

23 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004265022-Trans1(6-chloro-3-phenylindan-1-yl)-3,3-dime thylpiperazine

2004265020-Cyclopropyl derivatives as NK3 receptor antagonists